Propanc Biopharma, Inc. (PPCB)
- Sector
- Healthcare
- Industry
- Biotechnology
- Last price
- $1.77
- As of
Kresmion compiles this page from PPCB's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
Propanc Biopharma, Inc. (PPCB): 1 institutional manager tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-10-29.
See the full PPCB dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for PPCB on one page. Preview it with sample data, then open it live with a free account.
Preview the PPCB dossierActive events for PPCB
- medium13F: new position
CITADEL ADVISORS LLC new position in PPCB
FREE, NO ACCOUNT
Every event on PPCB, as it fires
New filings, 13F moves and cross asset events on PPCB land in the record first.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
PPCB positions held by the managers we follow (2026Q2)
What the managers we follow bought and sold in Q2 2026
| Manager / security | Market value | % of reported value |
|---|---|---|
| CITADEL ADVISORS LLC FundCUSIP 74346N800 · 2026Q2 | $18K | 0.00% |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. The share of reported value is each position's value over the sum of the values that manager reported for the quarter; option lines are not in that sum, as on each fund page. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, PPCB
- 8-KSEC EDGAR ↗
- 10-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
Going concern statement
PPCB's 10-K filed Sep 25, 2026 states:
The foregoing raises substantial doubt about our ability to continue as a going concern for a period of 12 months from the issue date of this report.
Read the 10-K on SEC EDGAR Every company with a going concern statement
More data on PPCB
PPCB against its peers
PPCB's return on equity of -200.6% ranks in the 54th percentile of 13 Biotechnology sub-industry peers, fiscal periods ending between 2025-12-31 and 2026-06-30.
| Metric | PPCB | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | n/a | 1.9M | n/a | 8 |
| Operating margin | n/a | -869.3% | n/a | 9 |
| Net margin | n/a | -862.3% | n/a | 9 |
| Return on equity | -200.6% | -203.8% | 54 | 13 |
Peers (19): EMMA, GNPX, KPTI, KAPA, GOVX, BRTX, OGEN, PPBT, SLXN, CASIF, HCWB, REVB, ATXI, ACUT, APVO, AGTX, VIVS, BDRX, CLDI. Left out: ENLV (no annual filing), XRTX (no annual filing), AGNPF (no annual filing), GPLL (period gap), ELAB (no annual filing), CLSDQ.D (no annual filing). Fiscal periods ending between 2025-12-31 and 2026-06-30. Every figure is one full fiscal year read from one annual filing (PPCB: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
Cite this data
Kresmion counts the managers it follows that reported a non-option position in PPCB on Form 13F-HR for the latest reporting quarter, orders those positions by the value each filing reports, and lists the company's latest SEC filings and the events Kresmion recorded on PPCB in the last 180 days.
Upstream: SEC EDGAR filings for PPCB
Kresmion, "Propanc Biopharma, Inc. (PPCB) institutional holdings and SEC filings", data as of 2026-10-29, https://kresmion.com/research/PPCB. Upstream data: SEC EDGAR filings for PPCB.
Link to this data (HTML):
<a href="https://kresmion.com/research/PPCB">Propanc Biopharma, Inc. (PPCB) institutional holdings and SEC filings (Kresmion)</a>
Writing about this? Press contact and ready-to-quote figures
Follow PPCB on a live board
Kresmion is a source-first market terminal for cross-asset market intelligence. Open a board scoped to PPCB for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.